A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 Mg Qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Celecoxib (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 21 Jan 2008 The expected completion date for this trial is now 1 Mar 2008.
- 04 Dec 2005 New trial record.